Benfotiamina

Melgama 300 MG Comprimidos Recubiertos con Pelicula

300 mg comprimido recubierto con películaSpainAuthorisedAuthorised 23 Jun 2025

In other countries

The same active substances on other registers, the same brand first.

Milgamma® mono 300Serbia · 300mg · film tableta · PredstavniŠTvo Worwag Pharma GMBH & Co.KG (Novi Beograd)Same form
BenfibeBrazil · Myralis Indústria Farmacêutica LtdaSame substance
benfotiaminaBrazil · Aché Laboratórios Farmacêuticos S.ASame substance
benfotiaminaBrazil · Biolab Sanus Farmacêutica LtdaSame substance
NEUROSSEN 300 mgRomania · 300mg · compr. film. · AaaSame substance
TIAVELLA 300 mgRomania · 300 mg · compr. film. · G.L. Pharma GMBHSame substance

Packs

Pack	Code	Status
MELGAMA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 10 comprimidos	767986

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Benfotiamina

Melgama 300 MG Comprimidos Recubiertos con Pelicula

300 mg comprimido recubierto con películaSpainAuthorisedAuthorised 23 Jun 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
MELGAMA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 10 comprimidos	767986

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Benfotiamina
Strength: 300 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 23 Jun 2025
Registration: 90406
Marketing authorisation holder: Aaa-Pharma Gmbh
Procedure: National, MRP or DCP
Supply: Sin Receta